The Zhitong Finance App learned that biotech company Electra Therapeutics Inc. (ETRA.US) has officially submitted an initial public offering (IPO) application to raise funds for its clinical-stage immune-mediated disease and cancer drug pipeline using Dongfeng's strong IPO performance in the biotech sector this year.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.